Abstract
Cryptococcus neoformans is a yeast-like fungus that is pathogenic to both animals and man. It was first isolated in 1894 by Busse (1) from a patient with osteomyelitis of the tibia. The fungus is a saprophitic organism that can be found in soil, on a variety of fruits, as well as in close association with pigeon nests (2,3). There are two varieties of C. neoformans: C. neoformans var. neoformans and C. neoformans var. gattii. Each of these varieties, in turn, has two serotypes: A and D for var. neoformans, and B and C for var. gattii. In addition, there have been reports of human infections caused by two other Cryptococcus species: C. albidus and C. laurentii.
Chapter PDF
Keywords
- Acquire Immunodeficiency Syndrome
- Cryptococcus Neoformans
- Cryptococcal Meningitis
- Oral Fluconazole
- Cryptococcal Infection
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Busse, O. Über Parasitare zelleinschlusse and ihre Zuchtung. Centralbl. Bakt, 16, 175, 1894.
Colmers, R. A„ Irniger, W., and Steinberg, D. H. Cryptococcus neoformans endocarditis cured by amphotericin. J. Am. Med. Assoc, 199, 762, 1967.
Arasteh, K., Staib, F., Grosse, G., Futh, U., and L’ Age, M. Cryptococcosis in HIV infection of man: an epidemiological and immunological indicator? Zentralbl. Bakteriol, 284, 153, 1996.
Littman, M. C. and Walter, J. E. Cryptococcosis: current status. Am. J. Med, 45, 922, 1968.
Sabetta, J. R., and Andriole, V. T. Cryptococcal infection of the central nervous system. Med. Clin. North Am., 69, 333, 1985.
Butler, W. T., Ailing, D. W., Spickard, A., and Utz, J. P. Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis. N. Engl. J. Med, 270, 59, 1964.
De Wytt, C. N., Dickson, P. L., and Holt, G. W. Cryptococcal meningitis: a review of 32 years’ experience. J. Neurol. Sci, 53, 283, 1982.
Sarosi, G. A., Parker, J. D., Doto, I. L., and Tosh, F. E. Amphotericin B in cryptococcal meningitis: long-term results of treatment. Ann. Intern. Med, 71, 1079, 1969.
Spickard, A., Butler, W. T., Andriole, V., and Utz, J. P. The improved prognosis of cryptococcal meningitis with amphotericin B therapy. Ann. Intern. Med, 58, 66, 1963.
Utz, J. P., Garriques, I. L., Sande, M. A., et al. Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J. Infect. Dis, 132, 368, 1975.
Zimmerman, L. E. and Rappaport, H. Occurence of cryptococcosis in patients with malignant disease of the reticuloendothelial system. Am. J. Clin. Pathol, 24, 1050, 1954.
Perfect, J. R., Durack, D. T., and Gallis, H. A. Cryptococcemia. Medicine (Baltimore), 62, 98, 1983.
Graybill, J. R. and Alford, R. H. Cell-mediated immunity in cryptococcosis. Cell. Immunol, 14, 12, 1974.
Schimpff, S. C. and Bennett, J. E. Abnormalities in cell-mediated immunity in patients with C. neoformans infections. J. Allergy Clin. Immunol, 55, 430, 1975.
Krick, J. A. Familial cryptococcal meningitis. J. Infect. Dis, 143, 133, 1981.
Ieong, M. H., Reardon, C. C., Levitz, S. M., and Kornfeld, H. Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity. Am. J. Respir. Crit. Care Med, 162 (3 Pt. 1), 966–970, 2000.
Mambula, S. S., Simons, E. R., Hastey, R. P., and Levitz, S. M. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Abstr. 99th Abstr. Gen. Meet. Am. Soc. Microbiol, May 30—June 3, 303, abstract F-42, 1999.
Aguirre, K., Havell, E. A., Gibson, G. W., and Johnson, L. L. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun, 63, 1725, 1995.
Kawakami, K., Koguchi, Y., Qureshi, M. H., et al. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J. Immunnol, 165, 941–947, 2000.
Watanabe, H., Inukai, A., Doyu, M., and Sobue, G. CNS cryptococcosis with idiopathic CD4+ T lymphocytopenia. Rinsho Shinkeigaku, 40, 249–253, 2000.
Kerkering, T. M., Duma, R. J., and Shadomy, S. The evolution of pulmonary cryptococcosis. Ann. Intern. Med, 94, 611, 1981.
Reblin, T., Meyer, A., Albrecht, H., and Greten, H. Disseminated cryptococcosis in a patient with AIDS. Mycoses, 37, 275, 1994.
Sarosi, G. A., Silberfarb, P. M., and Tosh, F. E. Cutaneous cryptococcosis: a sentinel of disseminated disease. Arch. Dermatol, 104, 1, 1971.
Srur, E., Misad, C., and Henriquez, A. Extrameningeal cryptococcosis in a patient with AIDS. Rev. Med. Chil, 123, 1009, 1995.
Houston, S., Lipp, K., Cobian, L., and Sinnott, J. T. Skin rash in a renal transplant recipients. Hosp. Pract. (Off. Ed.), 30, 89, 1995.
Haight, D. O., Esperanza, L. E., Greene, J. N., et al., Case report: cutaneous manifestations of cryptococcosis. Am. J. Med. Sci, 308, 192, 1994.
Abraham, K. A., Little, M. A., Casey, R., Smyth, E., and Walshe, J. J. A novel presentation of cryptococcal infection in a renal allograft recipient. Ir. Med. J, 93, 82–84, 2000.
Gosling, H. R. and Gilmer, W. S. Skeletal cryptococcosis: report of a case and review of the literature. J. Bone Joint Surg, 38A, 660, 1956.
Hinchey, W. W. and Someren, A. Cryptococcal prostatis. Am. J. Clin. Pathol, 75, 257, 1981.
Randal, R. E. Jr., Stacy, W. K., Prout, G. R. Jr., et al. Cryptococcal pyelonephritis. N. Engl. J. Med, 279, 60, 1968.
Okun, E. and Butler, W. T. Ophthalmologic complications of cryptococcal meningitis. Arch. Ophthalmol, 71, 52, 1964.
Weiss, C., Perry, I. H., and Shevky, M. C. Infections of the human eye with Cryptococcus neoformans (Torula histolytica). Arch. Ophthalmol, 39, 739, 1948.
Procknow, J. J., Benfield, J. R., Ripon, J. W., Diener, C. F., and Archer, F. L. Cryptococcal hepatitis presenting as a surgical emergency. J. Am. Med. Assoc, 191, 269, 1965.
Sabesin, S. M., Fallon, H. J., and Andriole, V. T. Hepatic failure as a manifestation of cryptococcosis. Arch. Intern. Med, 111, 661, 1963.
Goenka, M. K., Mehta, S., Yachha, S., Nagi, B., Chakraborty, A., Malik, A. K. Hepatic involvement culminating in cirrhosis in a child with disseminated cryptococcosis. J. Clin. Gastroenterol, 20, 57, 1995.
Baker, R. D. and Haugen, R. K. Tissue damages and tissue diagnosis in cryptococcosis. Am. J. Clin. Pathol, 25, 14, 1955.
Bowman, H. E. and Ritchey, J. O. Cryptococcosis (torulosis) involving brain, adrenal, and prostate. J. Urol,71, 373, I954.
Voyles, G. O. and Beck, E. M. Systemic infection due to Torula histolytica (C. hominis): report of four cases and review of the literature. Arch. Intern. Med, 77, 504, 1946.
Zelman, S., O’Neil, H., and Plaut, A. Disseminated visceral torulosis without nervous system involvement with clinical appearance of granulocytic leukemia. Am. J. Med, 11, 568, 1951.
Poliner, J. R., Wilkins, E. B., and Fernald, G. W. Localized osseous cryptococcosis. J. Pediatr, 94, 597, 1979.
Goldman, M. and Pottage, J. C. Jr. Cryptococcal infection of the breast. Clin. Infect. Dis, 21, 1166, 1995.
Merwaha, R. K., Trehan, A., Jayashree, K., and Vasishta, R. K. Hypereosinophilia in disseminated cryptococcal disease. Pediatr. Infect. Dis. J, 14, 1103, 1995.
Larsen, R. A., Bozzette, S., McCutchan, J. A., et al. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann. Intern. Med, 111, 125, 1989.
Fuse, H., Ohkawa, M., Yamaguchi, K., Hirata, A., and Matsubara, F. Cryptococcal prostatitis in a patient with Behcet’s disease treated with fluconazole. Mycopathologia, 130, 147, 1995.
Glassman, S. J. and Hale, M. J. Cutaneous cryptococcosis and Kaposi’s sarcoma occuring in the same lesions in a patient with the acquired immunodeficiency syndrome. Clin. Exp. Dermatol, 20, 480, 1995.
Muccioli, C., Belfort Junior, R., Neves, R., and Rao, N. Limbal and choroidal Cryptococcus infection in the acquired immunodeficiency syndrome. Am. J. Ophthalmol, 120, 539, 1995.
Benard, G., Gryschek, R. C., Duarte, A. J., and Shakanai-Yasuda, M. A. Cryptococcosis as an opportunistic infection in immunodeficiency secondary to paracoccidioidomycosis. Mycopathologia, 133, 65, 1996.
Molnar-Nadasdy, G., Haesly, I., Reed, J., and Altshuler, G. Placental cryptococcosis in a mother with systemic lupus erythematosus. Arch. Pathol. Lab. Med, 118, 757, 1994.
Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S., and Rahal, J. J. Cryptococcal disease in patients with acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann. Intern. Med, 104, 234, 1986.
Kovacs, J. A., Kovacs, A. A., Polis. M., et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Intern. Med, 103, 533, 1985.
Dismukes, W. E., Cloud, G., Gallis, H. A., et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N. Engl. J. Med, 317, 334, 1987.
Eng, R. H.K., Bishburg, E., Smith, S. M., and Kapila, R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am. J. Med, 81, 19, 1986.
Theunissen, A. W. J. and Zanen, H. C. Dertig petienten net een “verborgen” ziekte: cryptococcen-meningitis. Ned. Tijdschr. Geneeskd, 131, 1123, 1987.
Castro Guardiola, A., Ocana Rivera, I., Gasser Laguna, I., et al. 16 cases of infections by Cryptococcus neoformans in patients with AIDS. Enferm. Infec. Microbiol. Clin, 9, 90, 1991.
Sugar, A. M. Overview: cryptococcosis in the treatment of AIDS. Mycopathologia, 114, 153, 1991.
Fur, B. Cryptococcosis in AIDS: therapeutic concepts. Mycoses, 33 (Suppl.1), 55, 1990.
Kirchner, J. T. Opportunistic fungal infections in patients with HIV disease: combating cryptococcosis and histoplasmosis. Postgrad. Med, 99, 209, 1996.
Mitchell, T. G. and Perfect, J. R. Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev, 8, 515, 1995.
Just-Nübling, G. Therapy of candidiasis and cryptococcosis in AIDS. Mycoses, 37 (Suppl. 2), 56, 1994.
Emmons III, W. W., Luchsinger, S., and Miller, L. Progressive pulmonary cryptococcosis in a patient who is immunocompetent. South. Med. J, 88, 657, 1995.
Munoz-Peréz, M. A., Colmenero, M. A., Rodriguez-Pichardo, A., Rodriguez-Pinero, F. J., Rios, J. J., and Camacho, F. Disseminated cryptococcosis presenting as moluscum-like lesions as the first manifestation of AIDS. Int. J. Dermatol, 35, 646, 1996.
Gonzalez, C. E., Shetty, D., Lewis, L. L., Mueller, B. U., Pizzo, P. A., and Walsh, T. J. Cryptococcosis in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J, 15, 796, 1996.
Littman, M. L. and Zimmerman, L. E. Cryptococcosis. Grune Stratton, New York, 1956.
Haugen, R. K. and Baker, R. D. The pulmonary lesions in cryptococcosis with special reference to subpleural nodules. Am. J. Clin. Pathol, 24, 1381, 1954.
Talerman, A., Bradley, J. M., and Woodland, B. Cryptococcal lymphadenitis. J. Med. Microbiol, 3, 633, 1970.
Salyer, W. R., Salyer, D. C., and Baker, R. D. Primary complex of Cryptococcus and pulmonary lymph nodes. J. Infect. Dis., 130, 74, 1974.
Houk, V. N. and Moser, K. M. Pulmonary cryptococcosis: must all receive amphotericin B. Ann. Intern. Med, 63, 583, 1965.
Campbell, G. D. Primary pulmonary cryptococcosis. Am. Rev. Respir. Dis, 94, 236, 1966.
Duperval, R., Hermans, P. E., Brewer, N. S., and Roberts, G. D. Cryptococcosis with emphasis on the significance of isolation of C. neoformans from the respiratory tract. Chest, 72, 13, 1977.
Hammerman, K. J., Powell, K. E., and Christianson, C. S. Pulmonary cryptococcosis: clinical forms and treatment - CDC cooperative mycoses study. Am. Rev. Respir. Dis, 108, 1116, 1973.
Gurevitz, O., Goldschmiedt-Reuven, A., Block, C., Kopolovic, J., Farfel, Z., and Hassin, D. Cryptococcus neoformans vertebral osteomyelitis. J. Med. Vet. Mycol, 32, 315, 1994.
Anthony, S. A. and Anthony, S. J. Primary cutaneous cryptococcosis in nonimmunocompromised patients. Cutis, 56, 96, 1995.
Gordon, P. M., Ormerod, A. D., Harvey, G., Atkinson, P., and Best, P. V. Cutaneous cryptococcal infection without immunodeficiency. Clin. Exp. Dermatol, 19, 181, 1994.
Mahida, P., Morar, R., Goolam Mohamed, A., Song, E., Tissandie, J. P., and Feldman, C. Cryptococcosis: an unusual cause of endobronchial obstruction. Eur. Respir. J, 9, 837, 1996.
Schepelmann, K., Muller, F., and Dichgans, J. Cryptococcal meningitis with severe visual and hearing loss and radiculopathy in a patient without immunodeficiency. Mycoses, 36, 429, 1993.
Vender, J. R., Miller, D. M., Roth, T., Nair, S., and Reboli, A. C. Intraventricular cryptococcal cysts. AJNR Am. J. Neuroradiol, 17, 110, 1996.
Yu, F. C., Perng, W. C., Wu, C. P., Shen, C. Y., and Lee, H. S. Adult respiratory distress syndrome caused by pulmonary cryptococcosis in an immunocompetent host: a case report. Chung Hua I Hsueh Tsa Chih (Taipei), 52, 120, 1993.
Hellman, R. N., Hinrichs, J., Sicard, G., Hoover, R., Golden, P., and Hoffsten, P. Cryptococcal pyelonephritis and disseminated cryptococcosis in a renal transplant recipient. Arch. Intern. Med, 141, 128, 1984.
Liss, H. P. and Rimland, D. Asymptomatic cryptococcal meningitis. Am. Rev. Respir. Dis, 124, 88, 1981.
Tarala, R. A. and Smith, J. D. Cryptococcosis treated by rapid infusion of amphotericin B. Br. Med. J., 281, 28, 1980.
Mosberg, W. H. and Arnold, J. G. Torulosis of the central nervous system: review of the literature and report of five cases. Ann. Intern. Med, 32, 1153, 1950.
Beeson, P. B. Cryptococcal meningitis of nearly sixteen years’ duration. Arch. Intern. Med, 89, 797, 1952.
Campbell, G. D., Carrier, R. D., and Busey, J. F. Survival in untreated cryptococcal meningitis. Neurology, 31, 1154, 1981.
Carton, C. A. and Mount, L. A. Neurosurgical aspects of cryptococcosis. J. Neurosurg, 8, 143, 1951.
Powderly, W. G. Recent advances in the management of cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis, 22 (suppl. 2), S119, 1996.
Dismukes, W. E. Management of cryptococcosis. Clin. Infect. Dis, 17(Suppl. 2), S507, 1993 [see also: Clin. Infect. Dis, 19, 975, 1994 ].
Powderly, W. G. Current approach to the acute management of cryptococcal infections. J. Infect, 41, 18–22, 2000.
Saag, M. S., Graybill, R. J., Larsen, R. A., et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin. Infect. Dis, 30, 710–718, 2000.
Van der Horst, C., Saag, M., Cloud, G., et al. Randomized double blind comparison of amphotericin B (AMB) plus flucytosine to AMB alone (step 1) followed by a comparison of fluconazole to itraconazole (step 2) in the treatment of acute cryptococcal meningitis in patients with AIDS. Part I, 35th Intersci. Conf. Antimicrob. Agents Chemother, American Society for Microbiology, Washington, DC, abstract I - 216, 1995.
Nightingale, S. D. Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole. Arch. Intern. Med, 13, 538, 1995.
Saag, M. S., Powderly, W. G., Cloud, G. A., et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N. Engl. J. Med, 326, 83, 1992.
Haubrich, R. H., Haghighat, D., Bozzette, S. A., Tilles, J., and McCutchan, J. A. High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. J. Infect. Dis, 170, 238, 1994.
93. Meyohas, M. C., Meynard, J. L., Bollens, D., et al. Treatment of non-meningeal cryptococcosis in patients with AIDS J. Infect.33, 7, 1996
Sitbon, O., Fourme, T., Bouree, P., Du Pasquier, L., and Salmeron, S. Successful treatment of disseminated Cryptococcusis with high-dose oral fluconazole. AIDS, 7, 1685, 1993.
Ammassari, A., Linzalone, A., Murri, R., Marasca, G., Morace, G., and Antinori, A. Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case controlled study. Scand. J. Infect. Dis, 27, 235, 1995.
Nelson, M. R., Fisher, M., Cartledge, J., Rogers, T., and Gazzard, B. G. The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. AIDS, 8, 651, 1994 [see also: AIDS, 9, 300, 1995 ].
Manfredi, R., Mastroianni, A., Coronado, O. V., and Chiodo, F. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection. Arch. Intern. Med, 157, 64, 1997
Georgiev, V. St. Opportunistic/nosocomial infections: treatment and developmental therapeutics. I. Cryptococcosis. Med. Res. Rev, 13, 493–506, 1993.
Fernandez-Concepcion, O., Ariosa-Acuna, M. C., Giroud-Benitez, J. L., Pando-Cabrera, A., Garcia-Fidalgo, J A., and MestreMiguelez, R. Cryptococcosis of the central nervous system. A report of five cases. Rev. Neurol, 30, 935–938, 2000.
Emmons, C. W., Binford, C. H., and Utz, J. P. Medical Mycology, 2nd ed. Lea Fabiger, Philadelphia, 190, 1970.
Zuger, A., Schuster, M., Simberkoff, M. S., Rahal, J. J., and Holzman, R. S. Maintenance amphotericin B for cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med, 109, 592, 1988.
Holmberg, K. and Meyer, R. D. Fungal infections in patients with AIDS and AIDS-related complex. Scand. J. Infect. Dis, 18, 179, 1986.
Chechani, V. and Kamholz, S. L. Optimal therapy of cryptococcosis in patients with the acquired immunodeficiency syndrome. NY State J. Med, 91, 292, 1991.
de Lalla, F., Pellizzer, G., Vaglia, A., et al., Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period. Clin. Infect. Dis, 20, 263, 1995.
Churchill, D. and Coker, R. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses over a relatively short period. Clin. Infect. Dis, 21, 1352, 1995.
de Lalla, F., Pellizzer, G., Vaglia, A., et al. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses over a relatively short period: a reply. Clin. Infect. Dis, 21, 1353, 1995.
Diamond, R. D. and Bennett, J. E. A subcutaneous reservoir for intrathecal therapy of fungal meningitis. N. Engl. J. Med, 288, 186, 1973.
Polsky, B., Depman, M. R., Gold, J. W. M., Galicich, J. H., and Armstrong, D. Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Am. J. Med, 81, 24, 1986.
Roberts, N. J. and Douglas, R. G. Cryptococcal meningitis: cure despite cryptococcemia. Arch. Neurol, 35, 179, 1978.
Sapico, F. L. Disappearance of focal cryptococcal brain lesion on chemotherapy alone. Lancet, 1, 560, 1979.
Bastin, R., Vildé, J. L., Drouhet, E., and Carbon, C. Primary meningitis due to Cryptococcus neoformans associated with polyradiculitis: cure by amphotericin B. Sem. Hop. Paris, 50, 337, 1974.
Sugar, A. M., Stern, J. J., and Dupont, B. Overview: treatment of cryptococcal meningitis. Rev. Infect. Dis, 12 (Suppl 3), 5338, 1990.
Hay, R. J. Use of ambisome, liposomal amphotericin B in systemic fungal infections: preliminary findings of a European multicenter study, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takeuchi, H., Eds. Marcel Dekker, New York, 323, 1992.
Coker, R., Tomlinson, D., and Harris, J. Successful treatment of cryptococcal meningitis with liposomal amphotericin B after failure of treatment with fluconazole and conventional amphotericin B. AIDS, 5, 231, 1991.
Schurmann, D., de Matos Marques, B., Grunwald, T., Pohle, H. D., Hahn, H., and Ruf, B. Safety and efficacy of liposomal amphotericin B in treating AIDS-associated disseminated cryptococcosis. J. Infect. Dis, 164, 620, 1991.
Ikemoto, H., Yashiro, M., Furugori, T., and Kudo, Y. Unusual treatment of cryptococcal meningitis successfully treated with a small amount of amphotericin B, a large amount of prednisolone, and continued removal of cerebrospinal fluid. J. Antibiot, 20, 374, 1967.
Yashiro, M., Furugori, T., Kudo, Y., and Ikemoto, H. Cryptococcal meningitis successfully treated with amphotericin B, adrenal corticosteroid, and continuous removal of the cerebrospinal fluid. Naika, 20, 1155, 1967.
Brisman, R., Reid, R., and Harrington, G. Intracranial cryptococcal granuloma - amphotericin B and surgical excision. Surg. Neurol, 1, 43, 1973.
Dillon, M. C. and Sealy, W. C. Surgical aspects of opportunistic fungus infection. Lab. Invest, 11, 1231, 1962.
Reeves, D. C. Cryptococcic (Torula) granuloma of the scull. J. Neurol, 27, 70, 1967.
Rish, B. L. and Meacham, W. F. Intracerebral cystic toruloma. J. Neurosurg, 28, 603, 1968.
Vijayan, N., Bhatt, G. P., and Dreyfus, P. M. Intraventricular cryptococcal granuloma. Neurology, 21, 728, 1971.
Einstein, H. E., Brown, J. F., and Holmes, C. W. Some treatment aspects of coccidioidal meningitis, in Progress Report of the VA-Armed Forces Coccidioidomycosis Study Group No 7, Salkin, D. and Huppert, M., Eds. California VA Hospital, San Francisco, 17, 1969.
Pappagianis, D. Meningitis in children, in Progress Report of the VA- Armed Forces Coccidioidomycosis Study Group No 8, Salkin, D. and Hupper, M., Eds. California VA Hospital, San Francisco, 16, 1969.
Schonheyder, H., Thestrup-Pedersen, K., Esmann, V., and Stenderup, A. Cryptococcal meningitis: complications due to intrathecal treatment. J. Infect. Dis, 12, 155, 1980.
Swenson, R. S., Kountz, S. L., Blank, N., and Merigan, T. C. Successful renal allograft in a patient with pulmonary cryptococcosis. Arch. Intern. Med, 124, 502, 1969.
Oka, S., Sugimoto, H., and Shimada, K. Problems in the treatment of fungal infections after renal transplantation in Japan, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takeuchi, H., Eds. Marcel Dekker, New York, 239, 1992.
Shindo, K. Treatment of cryptococcal meningitis with five antifungal drugs: the role of amphotericin B. Drugs Exp. Clin. Res, 16, 327, 1991.
Liu, Y. C., Cheng, D. L., Liu, C. Y., Yen, M. Y., and Wang, R. S. Isolated cryptococcosis of the adrenal gland. J. Intern. Med, 230, 285, 1991.
Perkins, W. Pulmonary cryptococcosis: report on the treatment of nine cases. Dis. Chest, 56, 398, 1969.
Lopez-Berestein, G., Fainstein, V., Hersh, E. M., et al. Treatment of disseminated fungal infections in mammals with liposome-encapsulated amphotericin B. U.S. Patent 4, 663, 167, 1987.
Fajardo, L. F. Failure of topical amphotericin B in cryptococcosis. Ann. Intern. Med, 78, 777, 1973.
Kojima, T., Matsuzaki, M., Sano, M., et al. Acute lymphocytic leukemia, complicated with generalized cryptococcosis successfully treated by amphotericin B: a case report. Rinsho Ketsueki, 26, 217, 1985.
Lerner, P. I. and Weinstein, L. Infective endocarditis in the antibiotic era. N. Engl. J. Med, 274, 388, 1966.
Lombardo, T. A., Rabson, A. D., and Dodge, H. T. Mycotic endocarditis: report of a case due to Cryptococcus neoformans. Am. J. Med, 22, 664, 1957.
Miller, R. P. and Bates, J. H. Amphotericin B toxicity: a follow-up report of 53 patients. Ann. Intern. Med, 71, 1089, 1969.
Ellincy, B. R. Amphotericin B usage in pregnancy complicated by cryptococcosis. Am. J. Obstet. Gynecol, 115, 285, 1973.
Silberfarb, P. M., Sarosi, G. A., and Tosh, F. E. Cryptococcosis and pregnancy. Am. J. Obstet. Gynecol, 112, 714, 1972.
Li, P. K. and Lai, K. N. Amphotericin B induced ocular toxicity in cryptococcal meningitis. Br. J. Ophthalmol, 73, 397, 1989.
Kaminaga, Y., Shindo, K., Ito, A., and Iizuma, H. Mycological and clinical study of cryptococcosis in Yokohama City University Hospital during the period from 1965 to 1989. Kansenshogaku Zasshi, 65, 374, 1991.
Armstrong, D. Treatment of fungal infections in the immunocompromised host, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, S. G., and Takeuchi, H., Eds. Marcel Dekker, New York, 251, 1992.
Hackett, A. J., Sylvester, S. S., Joss, U. R., and Calvin, M. Synergistic effect of rifamycin derivatives and amphotericin B on viral transformation of a murine cell line. Proc. Natl. Acad. Sci. USA, 69, 3653, 1972.
Kuwano, M., Akiyama, S., Endo, H., and Kohga, M. Potentiation of fusidic acid and lentinan effects upon normal and transformed fibroblastic cells by amphotericin B. Biochem. Biophys. Res. Commun, 49, 1241, 1972.
Medoff, G. and Kobayashi, G. S. Amphotericin B and 5-fluorocytosine. J. Infect. Dis, 132, 489, 1975.
Jimbow, T., Tejima, Y., and Ikemoto, H. Comparison between 5-fluorocytosine, amphotericin B and the combined administration of these agents in the therapeutic effectiveness for cryptococcal meningitis. Chemotherapy, 24, 374, 1978.
Bennett, J. E., Dismukes, W. E., Duma, R. J., et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N. Engl. J. Med, 301, 127, 1979.
MacGregor, R. R. Treatment of cryptococcal meningitis. N. Engl. J. Med, 318, 380, 1988.
Schmutzhard, E. and Vejajjiva, A. Treatment of cryptococcal meningitis with high-dose, long-term combination amphotericin B and flucytosine. Am. J. Med, 85, 737, 1988.
Sahai, J. Management of cryptococcal meningitis in patients with AIDS. Clin. Pharmacy, 7, 528, 1988.
Kauffman, C. A. and Frame, P. T. Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob. Agents Chemother, 11, 244, 1977.
Donahue, R. E., Johnson, M. M., Zon, L. I., Clark, S. C., and Groopman, J. E. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature, 326, 200, 1987.
Kotler, D. P., Gaetz, H. P., Lange, M., Klein, E. B., and Holt, P. R. Enteropathy associated with acquired immunodeficiency syndrome. Ann. Intern. Med, 101, 421, 1984.
Chuck, S. L. and Sande, M. A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N. Engl. J. Med, 321, 794, 1989.
Dismukes, W. E. Treatment of systemic fungal diseases in patients with AIDS, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takeuchi, H., Eds. Marcel Dekker, New York, 227, 1992.
Bayardelle, P., Giard, N., Maltais, R., Delorme, J., and Brazean, M. Success with amphotericin B and 5-fluorocytosine in treating cerebral cryptococcoma accompanying cryptococcal meningitis. Can. Med. Assoc. J, 127, 732, 1982.
Koeleman, J. G., Rustemejer, C., Wijermans, P. W., and MacLaren, D. M. Cryptococcal meningo-encephalitis after prolonged corticosteroid therapy. Neth. J. Med, 36, 242, 1990.
Carney, M. D., Combs, J. L., and Waschler, W. Cryptococcal choroiditis. Retina, 10, 27, 1990.
Picon, L., Vaillant, L., Duong, T., et al. Cutaneous cryptococcosis resembling molluscum contagiosum: a first manifestation of AIDS. Acta Derm. Venereo!. (Stockholm), 69, 365, 1989.
Tobias, J. S., Wrigley, P. F. M., and Shaw, E. Combination antifungal therapy for cryptococcal meningitis. Postgrad. Med. J, 52, 305, 1976.
Watson, A. J, Russell, R. P., Cabreja, R. F., Braverman, R., and Whelton, A. Cure of cryptococcal infection during continued immunosuppressive therapy. Q. J. Med, 55, 169, 1985.
Gallis, H. A., Berman, R. A., Cate, T. R., Hamilton, J. D., Gunnels, J.C., and Stickel, D. L. Fungal infection following renal transplantation. Arch. Intern. Med, 135, 1163, 1975.
Mills, S. A., Seigler, H. F., and Wolfe, W. G. The incidence and management of pulmonary mycosis in renal allograft patients. Ann. Surg, 182, 617, 1975.
Kong, N. C., Sharriah, W., Morad, Z., Suleiman, A. B., and Wong, Y. H. Cryptococcosis in a renal unit. Aust. N. Z. J. Med, 20, 645, 1990.
Kimura, K., Hatekayama, M., Miyagi, J., et al. A case of systemic lupus erythematosus with cryptococcal meningitis successfully treated with amphotericin B and 5-FC. Nipon Naika Gakkai Zasshi, 75, 406, 1986.
Butler, W. P. and Kaufer, G. I. Primary cutaneous cryptococcosis successfully treated with outpatient amphotericin B and 5-fluorocytosine. Nita, 8, 295, 1985.
Woolfitt, R., Park, H. M., and Greene, M. Localized cryptococcal osteomyelitis. Radiology, 120, 290, 1976.
Nottebart, H. C., McGehee, R. F., and Utz, J. P. Cryptococcus neoformans osteomyelitis: case report of two patients. Sabouraudia, 12, 127, 1974.
Chand, K. and Lan, K. S. Cryptococcosis of the knee joint. Acta Orthop. Scand, 47, 432, 1976.
Nathan, C. F. Cryptococcal osteomyelitis treated with 5-fluorocytosine. Am. Rev. Respir. Dis, 110, 78, 1974.
Luhr, H. and Svane, S. Pulmonary pseudomotor caused by Cryptococcus neoformans. Tidsskr. Nor. Laegeforen, 111, 3288, 1991.
Schmidt-Westhausen, A., Grunewald, T., Reihart, P. A., and Pohle, H. D. Oral cryptococcosis in a patient with AIDS: a case report. Oral. Dis, 1, 77, 1995 [see also: Oral Dis, 1, 61, 1995 ].
Iida, Y., Maehara, K., Okamoto, Y., et al. A case of cryptococcal meningitis treated by ketoconazole and amphotericin B combination therapy. Kansenshogaku Zasshi, 60, 189, 1986.
Echevarria, A., Pinzon, V., Toro, J., and Diaz Issacs, M. Pulmonary cryptococcosis. Rev. Med. Panama, 16, 50, 1991.
Aslam, P. A., Larkin, J., Eastridge, C. E., and Hughes, F. A. Endocavitary infusion through percutaneous endobronchial catheter. Chest, 57, 94, 1970.
Stamm, A. M., Diasio, R. B., Dismukes, W. E., et al. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am. J. Med, 83, 236, 1987.
Shindo, K., Mizuno, T., Matsumoto, Y., et al. Granulocytopenia and thrombocytopenia associated with combination therapy of amphotericin B and low-dose flucytosine in a patient with cryptococcal meningitis. DICP, 23, 672, 1989.
Bryan, C. S. and McFarland, J. A. Cryptococcal meningitis: fatal marrow applasia from combined therapy. J. Am. Med. Assoc., 239, 1068, 1978.
Tassel, D. and Madoff, M. A., Treatment of Candida sepsis and Cryptococcus meningitis with 5-fluorocytosine: a new antifungal agent. J. Am. Med. Assoc, 260, 830, 1968.
Sanati, H., Messer, S. A., Pfaller, M., et al. Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole. J. Clin. Microbiol, 34, 1280, 1996.
Koechlin, B. A., Rubio, S., Palmer, S., Gabriel, T., and Duschinsky, R. The metabolism of 5-fluorocytosine-2[14C] and cytosine[14C] in the rat and the disposition of 5-fluorocytosine- 2[14C] in man. Biochem. Pharmacol, 15, 435, 1966.
Shadomy, S. Further in vitro studies with 5-fluorocytosine. Infect. Immun, 2, 484, 1970.
Roberts, M., Rinaudo, P. A., Tilton, R. C., and Vilinskas, J. Treatment of multiple intracerebral cryptococcal granulomas with 5-fluorocytosine. J. Neurosurg, 37, 229, 1972.
Editorial. Cryptococcosis and 5-fluorocytosine. Aust. N. Z. J. Med, 4, 296, 1974.
Sabetta, J. R. and Andriole, V. T. Cryptococcal infections in the central nervous system. Med. Clin. North Am, 69, 334, 1985.
Block, E. R. and Bennett, J. E. Clinical and pharmacological studies with 5-fluorocytosine (5-FC). Clin. Res, 20, 525, 1972.
Utz, J. P., Shadomy, S., McGehee, R. F., and Tynes, B. S. 5-Fluorocytosine: experience in patients with pulmonary and other forms of cryptococcosis. Am. Rev. Respir. Dis, 99, 975, 1969.
Zylstra, W. Cryptococcosis and 5-fluorocytosine: comment. Aust. N. Z. J. Med, 4, 296, 1974.
Vandevelle, A. G., Nauceri, A. A., and Johnson III, J. E. 5-Fluorocytosine in the treatment of mycotic infections. Ann. Intern. Med, 77, 43, 1972.
Fass, R. J. and Perkins, R. L. 5-Fluorocytosine in the treatment of cryptococcal and Candida mycoses. Ann. Intern. Med, 74, 535, 1971.
Schlegel, R. J., Bernier, G. M., Bellanti, J. A., et al. Severe candidiasis asociated with thymic displasia, IgA deficiency and plasma antilymphocyte effects. Pediatrics, 45, 926, 1970.
McDonnell, F. I., Clunie, G. J. A., Petrie, J. J. G., and Rao, A. Experience with 5- fluorocytosine in a dialysis-transplant unit. Aust. N. Z. J. Med, 3, 438, 1973.
Kauffman, C. A. and Frame, P. T. Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob. Agents Chemother, 11, 244, 1977.
Bryan, C. S. and McFarland, J. A. Cryptococcal meningitis: fatal marrow aplasia from combined therapy. J. Am. Med. Assoc, 239, 1068, 1978.
Philpot, C. R. and Lo, D. Cryptococcal meningitis in pregnancy. Med. J. Aust, 2, 1005, 1972.
Deresinski, S. C., Lilly, R. B., Levine, H. B., Galgiani, J. N., and Stevens, D. A. Treatment of fungal meningitis with miconazole. Arch. Intern. Med, 137, 1180, 1977.
Ito, A., Therapeutic results with miconazole in Japan, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takeuchi, H., Eds. Marcel Dekker, New York, 183, 1991.
Sung, J. P., Grendale, J. G., and Levine, H. B., Intravenous and intrathecal miconazole therapy for systemic mycosis. West. J. Med, 126, 5, 1977.
Weinstein, L. and Jacoby, I., Successful treatment of cerebral cryptococcoma and meningitis with miconazole. Ann. Intern. Med, 93, 569, 1980.
Belle, W. E., Treatment of fungal infections of the central nervous system. Ann. Neurol, 9, 417, 1981.
Sung, J. P., Campbell, G. D., and Grendahl, J. C., Miconazole therapy for fungal meningitis. Arch. Neurol, 35, 443, 1978.
Perfect, J. R., Durack, D. T., Hamilton, J. D., and Gallis, H. A., Failure of ketoconazole in cryptococcal meningitis. J. Am. Med. Assoc, 247, 3349, 1982.
Ogushi, F., Tamura, M., Ozaki, T., et al. A case of cryptococcal meningitis improved in the treatment of high dose ketoconazole. Kansenshogaku Zasshi, 59, 405, 1985.
Karaffa, C. A., Rehm, S. J., and Keys, T. F. The acquired immunodeficiency syndrome and cryptococcosis. Ann. Intern. Med, 104, 891, 1986.
Granier, F., Kamitakis, J., Hermier, C., Zhu, Y. Y., and Thivolet, J. Localized cutaneous cryptococcosis successfully treated with ketoconazole. J. Am. Acad. Dermatol, 16, 243, 1987.
Bernard, E., Caries, M., Toussaint-Gari, M., Fournier, J. P., and Dellamonica, P. Value of fluconazole in the treatment of systemic yeast infection. Pathol. Biol. (Paris), 37, 690, 1989.
Shuttleworth, D., Philpot, C. M., and Knight, A. G. Cutaneous cryptococcosis: treatment with oral fluconazole. Br. J. Dermatol, 120, 683, 1989.
Nakashima, M. The clinical study of fluconazole against pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients. Jpn. J. Antibiot, 42, 127, 1989.
Mares, M., Sartori, M. T., Carretta, M., Bertaggia, A., and Girolami, A. Rhinophyma-like cryptococcal infection as an early manifestation of AIDS in a hemophilia B patient. Acta Haematol, 84, 101, 1990.
Zalcman, G., Lechapt, E., Milleron, B., Denis, M., Mayaud, C., and Akoun, G. Pleuropulmonary cryptococcosis disclosing AIDS. Rev. Pneumol. Clin, 47, 133, 1991.
Bozzette, S. A., Larsen, R. A., Chiu, J., et al. Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Ann. Intern. Med, 115, 285, 1991.
Sugar, A. M. Overview: cryptococcosis in the treatment of AIDS. Mycopathologia, 114, 153, 1991.
Levesque, H., Alie-Legrand, M. C., Omnient, Y., et al. Cryptococcus neoformans meningitis and cirrhosis: value of fluconazole. Clin. Biol., 13, 942, 1989.
Michelone, G., Tacconi, F., Maccabruni, A., Lanzarini, P., Tinelli, M., and Dei Cas, A. Clinical and therapeutic profile of 3 cases of cryptococcal meningitis in patients with AIDS. G. Ital. Chemoter, 36, 95, 1989.
Krisch, H. and Sarnow, E. Collection of cases in relation to clinical trials of fluconazole in Germany. Mycoses, 33 (Suppl. 1), 145, 1990.
Reents, S. B. and Powell, G. Fluconazole success after amphotericin B and flucytosine failure in cryptococcal meningitis. DICP, 24, 885, 1990.
Lindberg, J. and Edebo, L. Successful treatment of cryptococcal meningitis with fluconazole. Lakartidningen, 88, 2245, 1991.
Good, C. B. and Leeper, H. F. Profound papilledema due to cryptococcal meningitis in acquired immunodeficiency syndrome: successful treatment with fluconazole. South. Med. J, 84, 394, 1991.
Dismukes, W. E. Treatment of systemic fungal diseases in patients with AIDS, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 227, 1992.
Jones, P. D., Marriott, D., and Speed, B. R. Efficacy of fluconazole in cryptoccocal meningitis. Diagn. Microbiol. Infect. Dis, 12 (Suppl. 4), 235S, 1989.
Dupont, B. Treatment of cryptococcal meningitis, in Proc. Xth Congr. Int. Soc. Human Animal Mycol., Barcelona, Torres-Rodriguez, J. M., Ed. J. R. Prous, 197, 1988.
Byrne, W. R. and Wajszczuk, C. P. Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B. Ann. Intern. Med, 108, 384, 1988.
Dromer, F., Mathoulin, S., Dupont, B., Brugiere, O., and Letenneur, L., Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. Clin. Infect. Dis, 22 (Suppl. 2), 5154, 1996.
Larsen, R. A., Leal, M. A., and Chan, L. S., Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial. Ann. Intern. Med, 113, 183, 1990.
Wong, R. D. and Goetz, M. B., Treatment of cryptococcal meningitis in AIDS. J. Infect. Dis, 113, 992, 1990.
Buxton, M. J., Dubois, D. J., Turner, R. R., Sculpher, M. J., Robinson, P. A., and Searcy, C., Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis: comparison of fluconazole and amphotericinbased therapies. J. Infect, 23, 17, 1991.
Bolignano, G., Chindemi, G., and Criseo, G., Cryptococcal meningoencephalitis in a patient with Hodgkin’s lymphoma: successful treatment with fluconazole. Mycoses, 34, 63, 1991.
Iacopino, P., Morabito, F., Martino, B., Bolignano, G., and Nobile, F., Fluconazole for disseminated cryptococcosis in a patient with Hodgkin’s disease. Haematologica, 76, 260, 1991.
Sugar, A. M. and Saunders, C. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am. J. Med, 85, 481, 1988.
Bozzette, S. A., Larsen, R. A., Chiu, J., et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N. Engl. J. Med, 324, 580, 1991.
Powderly, W., Saag, M., Cloud, G., et al., Fluconazole versus amphotericin B as maintenance therapy for prevention of relapse of AIDS-associated cryptococcal meningitis. 30th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC, abstract 1162, 1990.
Laroche, R., Deppner, M., Floch, J. J., et al. Cryptococcosis in Bujumbura, Burundi: apropos of 80 observed cases in 42 months. Bull. Soc. Pathol. Exot. Fil, 83, 159, 1990.
Stern, J. J., Hartman, B. J., Sharkey, K., et al. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am. J. Med, 85, 477, 1988.
Sort, P., Morales, M., Gomez, J., Pares, A., and Rodes, J. Pleural empyema caussed by Cryptococcus neoformans in a patient with liver cirrhosis. Gastroenterol. Hepatol, 19, 302, 1996.
Agarwal, A., Gupta, A., Sakhuja, V., Talwar, P., Joshi, K., and Chugh, K. S. Retinitis following disseminated
cryptococcosis in a renal allograft recipient: efficacy of oral fluconazole. Acta Ophthalmol (Copenhagen), 69, 402, 1991.
Custis, P. H., Haller, J. A., and de Juan, E. Jr. An unusual case of cryptococcal endophthalmitis. Reina, 15, 300, 1995.
Vandersmissen, G., Meuleman, L., Tits, G., Verhaeghe, A., and Peetermans, W. E. Cutaneous cryptococcosis in corticosteroid-treated patients without AIDS. Acta Clin. Belg, 51, 111, 1996.
Halweg, H., Korzeniewska-Kosela, M., Podsiadlo, B., and Krakowka, P. A case of skin cryptococcosis in systemic lupus erythematosus. Pneumonol. Pol., 58, 544, 1990.
Pineski, R., Mathurin, S. A., Ruffinengo, O., Alonso, H. O., and Corallini de Bracelenti, B. Cutaneous cryptococcosis in a patient receiving chronic immunosuppressive therapy. Cutis, 57, 229, 1996.
Verneuil, L., Dompmartin, A., Duhamel, C., et al. Cryptococcal whitlow in a HIV-positive patient. Ann. Dermatol. Venereal, 122, 688, 1995.
Kerchner, J. E., Ridley, M. B., and Greene, J. N. Laryngeal Cryptococcus: treatment with oral fluconazole. Arch. Otolaryngol. Head Neck Surg, 121, 1193, 1995.
Schmidt, D. M., Sercarz, J. A., Kevorkian, K. F., and Canalis, R. F. Cryptococcus presenting as a neck mass. Ann. Otol. Rhinol. Laryngol, 104, 711, 1995.
Yew, W. W., Wong, P. C., Wong, C. F., Lee, J., and Chau, C. H. Oral fluconazole in the treatment of pulmonary cryptococcosis in non-AIDS patients. Drugs Exp. Clin. Res, 22, 25, 1996.
Feczko, J. M. Overview of fluconazole in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 191, 1992.
Troke, P. F., Marriott, M. S., Richardson, K., and Tarbit, M. H. In vitro potency and in vivo activity of azoles. Ann. NY Acad. Sci, 544, 284, 1988.
Guillaume, M. P., De Prez, C., and Cogan, E. Subacute mitochondroal liver disease in a patient with AIDS: possible relationship to prolonged fluconazole administration. Am. J. Gastroenterol, 91, 165, 1996.
Pappas, P. G., Kauffman, C. A., Perfect, J., et al. Alopecia associated with fluconazole therapy. Ann. Intern. Med, 123, 354, 1995 [see comment in Ann. Intern. Med, 125, 153, 1996 ].
Weinroth, S. E., and Tuazon, C. U. Alopecia associated with fluconazole treatment. Ann. Intern. Med, 119, 637, 1993.
Coker, R. J. and Harris, J. R. Failure of fluconazole treatment in cryptococcal meningitis despite adequate CSF levels. J. Infect, 123, 101, 1991.
Bailly, M. P., Boibieux, A., Biron, F., et al. Persistence of Cryptococcus neoformans in prostate: failure of fluconazole despite high doses. J. Infect. Dis, 164, 435, 1991.
Pietroski, N., Buckley, R. M., Braffman, M. N., and Stern, J. J. Intravenous and oral fluconazole in treatment of acute cryptococcal meningitis in AIDS. 30th Intersci. Conf. Antimicrob. Agents Chemother, American Society for Microbiology, Washington, DC, abstract 576, 1990.
Squires, K., Rowland, V., Gassyuk, E., et al. Fluconazole as therapy for acute cryptococcal meningitis. 30th Intersci. Conf. Antimicrob. Agents Chemother, American Society for Microbiology, Washington, DC, abstract 573, 1990.
Aller, A. I., Martin-Mazuelos, E., Lozano, F., et al. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob. Agents Chemother, 44, 1544–1548, 2000.
Orni-Wasserlauf, R., Siegman-Igra, Y., Izkhakov, E., Bash, E., Polacheck, I., and Giladi, M. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole. 38th Intersci. Conf. Antimicrob. Agents Chemother, American Society of Microbiology, Washington, DC, 458, abstract J24, 1998.
Abi-Hanna, P., Marichal, P., Vandenbossche, H., and Williamson, P. R. Study of fluconazole resistance in Cryptococcus neoformans by insertional mutagenesis. 99th Abstr. Gen. Meet. Am. Soc. Microbiol., May 30—June 3, 6, abstract A29, 1999.
Georgiev, V. St. Opportunistic/nosocomial infections: treatment and developmental therapeutics. II. Cryptococcosis. Med. Res. Rev, 13, 507–527, 1993.
Van Cutsem, J. and Cauwenbergh, G. Results of itraconazole treatment in systemic mycoses in animals and man, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 203, 1992.
Viviani, M. A., Tortorano, A. M., Giani, P. C., et al. Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome. Ann. Intern. Med, 106, 106, 1987.
Viviani, M. A., Tortorano, A. M., Langer, M., et al. Experience with itraconazole in cryptococcosis and aspergillosis. J. Infect, 18, 151, 1989.
Denning, D. W., Tucker, R. M., Hanson, L. H., Hamilton, J. R., and Stevens, D. A. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch. Intern. Med, 149, 2301, 1989.
Denning, D. W., Tucker, R. M., Hanson, L. H., and Stevens, D. A. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis. J. Am. Acad. Dermatol, 3, 602, 1990.
de Gans, J., Eeftinck Schattenkerk, J. K. M., and van Ketel, R. J. Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immunodeficiency syndrome. Br. Med. J, 296, 339, 1988.
Batungwanayo, J., Taelman, H., Bogaerts, J., et al. Pulmonary cryptococcosis associated with HIV-1 infection in Rwanda: a retrospective study of 37 cases. AIDS, 8, 1271, 1994.
Sato, T., Koseki, S., Takahashi, S., and Maie, O., Localized cutaneous cryptococcosis successfully treated with itraconazole: review of medication in 18 cases reported in Japan. Mycoses, 33, 455, 1990.
Goh, C. L., Cutaneous cryptococcosis successfully treated with itraconazole. Cutis, 51, 377, 1993.
Bettoli, V., Virgili, A., Zampino, M. R., Bedetti, A., and Montanari, P., Cutaneous cryptococcosis in AIDS: successful treatment with itraconazole. Mycoses, 36, 433, 1993.
USPHS/IDSA guidelines for the prevention of opportunistic infections on persons infected with human immunodeficient virus. Infect. Dis. Obstetr. Gynecol, 8, 5–74, 2000 Clin. Infect. Dis, 30 (Suppl. 1), S29 — S65, 2000.
Powderly, W. G., Finkelstein, D. M., Feinberg, J., et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med, 332, 700–705, 1995.
Schuman, P., Capps, L., Peng, G., et al. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med, 126, 689–696, 1997.
Havlir, D. V., Dube, M. P., McCutchan, J. A., et al. Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. Clin. Infect. Dis, 27, 1369–1375, 1998.
Lewis, J. L. and Rabinovich, S. The wide spectrum of cryptococcal infections. Am. J. Med, 53, 315, 1972.
Lalloo, D., Fisher, D., Naraqi, S., et al. Cryptococcal meningitis (C. neoformans var.gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. Q. J. Med, 87, 343, 1994.
Currie, B., Vigus, T., Leach, G., and Dwyer, B. Cryptococcus neoformans var. gattii. Lancet, 336, 1442, 1990.
Laurenson, I. F., Naraqi, S., Howcroft, N., Burrows, I., and Saulei, S. Cryptococcal meningitis in Papua New Guinea: ecology and the role of eucalypts. Med. J. Aust, 158, 213, 1993.
Laurenson, I. F., Naraqi, S., Trevett, A., et al. Cryptococcal investigations in Papua New Guinea. Proc. 2nd Int. Conf. Cryptococcus Cryptococcosis, Milan, 114, 1993.
Laurenson, I. F., Trevett, A. J., Lalloo, D. G., et al. Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg, 90, 57, 1996.
Castanon-Olivares, L. R., Arreguin-Espinosa, R., Ruiz-Palacios y Santos, G., and Lopez- Martinez, R. Frequency of Cryptococcus species and varieties in Mexico and their comparison with some Latin American countries. Rev. Latinoam. Microbiol, 42, 35–40, 2000.
Kwon-Chung, K. J. and Bennett, J. E. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am. J. Epidemiol., 120, 123, 1984.
Ellis, D. H. Cryptococcus neoformans var. gattii in Australia. J. Clin. Microbiol, 25, 430, 1987.
Marriott, D. J., Speed, B. R., Spelman, D., Shaw, D., French, M., and Harkness, J. L. Cryptococcus neoformans var. gattii infections in Australian HIV-infected patients: a review of seven cases. 8th Annu. Conf. Australs. Soc. HIV Med., Nov. 14–17, 86, abstract 88, 1996.
Sorrell, T. C., Brownlee, A. G., Ruma, P., Malik, R., Pfeiffer, T. J., and Ellis, D. H. Natural environmental sources of Cryptococcus neoformans var. gattii. J. Clin. Microbiol, 34, 1261, 1996.
Pfeiffer, T. J. and Ellis, D. H. Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. J. Med. Vet. Mycol, 30, 407, 1992.
Sorrell, T. C., Chen, S. C. A., Ruma, P., et al. Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J. Clin. Microbiol, 34, 1253, 1996.
Kwon-Chung, K. J., Wickes, B. L., Stockman, L., Roberts, G. D., Ellis, D., and Howard, D. H. Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect. Immun, 60, 1869, 1992.
Varma, A., Swinne, D., Staib, F., Bennett, J. E., and Kwon-Chung, K. J. Diversity of DNA fingerprints in Cryptococcus neoformans. J. Clin. Microbiol, 33, 1807, 1995.
Mitchell, D. H., Sorrell, T. C., Allworth, A. M., et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin. Infect. Dis, 20, 611, 1995.
Speed, R. and Dunt, D. Clinical and host differences between the two varieties of Cryptococcus neoformans. Clin. Infect. Dis, 21, 28, 1995.
Slobodnik, R. and Naraqi, S. Cryptococcal meningitis, in the Central Province of Papua New Guinea. Papua New Guinea Med. J., 23, 111, 1980.
Peetermans, W., Bobbaers, H., Verhaegen, J., and Vandepitte, J. Fluconazole-resistant Cryptococcus neoformans var. gattii in an AIDS patient. Acta Clin. Belg, 48, 405–409, 1993.
Kamei, K., Brummer, E., Nishimura, K., and Miyaji, M. Activity of voriconazole against Cryptococcus neoformans var. gattii vs. var. neoformans: effect of human serum. Abstr. 98th Gen. Meet. Am. Soc. Microbiol., May 17–21, 270, abstract F-100, 1998.
Gluck, J. L., Myers, J. P., and Pass, L. M. Cryptococcemia due to Cryptococcus albidus. South. Med. J, 80, 511, 1987.
Gordon, M. A. Pulmonary cryptococcosis: a case due to Cryptococcus albidus. Am. Rev. Respir. Dis, 106, 786, 1972.
Lin, S. R., Peng, C. E., Yung, S. A., and Yu, H. S. Isolation of Cryptococcus albidus var. albidus in patient with pemphigus foliaceous. Kao-Hsiung I Hsueh Ko Hsueh Tsa Chih, 5, 126, 1989.
Weiser, H. G. Zur frage der pathogenität der Cryptococcus albidus. Schweiz. Med. Wochenschr, 103, 475, 1973.
da Cunha, T. and Lusins, J. Cryptococcus albidus meningitis. South. Med. J, 66, 1230, 1973.
295. Mello, J. C., Srinivasan, S., Scott, M. L., and Raff, M. J Cryptococcus albidus meningitis J. Infect., 2, 79, 1980
Krumholz, R. A. Pulmonary cryptococcosis: a case due to Cryptococcus albidus. Am. Rev. Respir. Dis, 105, 421, 1972.
Horowitz, I. D., Blumberg, E. A., and Krevolin, L. Cryptococcus albidus and mucormycosis empyema in a patient receiving hemodialysis. South. Med. J., 86, 1070, 1993.
Mckee, M., Arthington-Skaggs, B. A., Motley, M., et al. Distribution of yeast isolates recovered from the oral mucosa of HIV+ patients: relationship to antifungal drug use. Abstr. 99th Gen. Meet. Am. Soc. Microbiol., May 30—June 3, 137, abstract C-I61, 1999.
Loison, J., Bouchara, J. P., Gueho, E., et al. First report of Cryptococcus albidus septicemia in an HIV patient. J. Infect, 33, 139, 1996.
Kordossis, T., Avlami, A., Velegraki, A., et al. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Med. Mycol, 36, 335–339, 1998.
Lynch III, J. P., Schaberg, D. R., Kissner, D. G., and Kauffman, C. A. Cryptococcus laurentii lung abscess. Am. Rev. Respir. Dis, 123, 135, 1981.
Chander, J., Sapra, R. K., and Talwar, P. Incidence of cryptococcosis in and around Chandigarch, India during the period 1982–1991. Mycoses, 37, 23, 1994.
Custis, P. H., Haller, J. A., and de Juan, E. Jr. An unusual case of cryptococcal endophthalmitis. Reina, 15, 300, 1995.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Georgiev, V.S. (2003). Cryptococcus neoformans. In: Opportunistic Infections. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-296-8_19
Download citation
DOI: https://doi.org/10.1007/978-1-59259-296-8_19
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-303-9
Online ISBN: 978-1-59259-296-8
eBook Packages: Springer Book Archive